Kitakata H, Endo J, Matsushima H, Yamamoto S, Ikura H, Hirai A, Koh S, Ichihara G, Hiraide T, Moriyama H, Shirakawa K
The medication is administered once weekly via subcutaneous injection, with doses typically initiated at 2.5 mg once weekly for 4 weeks, then escalated (e.g., to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) based on response and tolerability as per the SmPC
CMs were obtained from PC-3, DU-145, LNCaP and BPH cells, pre-treated for 48 h, with ALCAR (1 or 10 mM), in serum-free RPMI medium
Jin Kui refrained from drinking, which prevented him from being fully engaged
This really suggests to me that affordability is a big concern in our healthcare system at multiple levels, Sinaiko said
Shao H, Fang C, Huang Y, Ye Y, Tong R